Xiao-Qi Tang

Xiao-Qi Tang

Auto-generated profile, based on publicly available information

Xiao-Qi Tang

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Pharmacological Research
Verified
Journal Article
Open access
YYYa-Xin Yan
Ya-Xin Yan
HZHua-Miao Zhou
Hua-Miao Zhou
XSXiao-Guang Shang
Xiao-Guang Shang
PXPei Xu
Pei Xu
XTXiao-Qi Tang
Xiao-Qi Tang
JLJianshu Lou
Jianshu Lou
Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, plays a critical role in various pathological conditions, including cancer and organ injury. Post-translational modifications (PTMs) dynamically regulate ferroptosis by modulating the stability, activity, and interactions of key proteins such as GPX4, SLC7A11, and ACSL4. A single protein can undergo multiple PTMs, and the same regulatory enzyme may exert opposing effects on ferroptosis by modifying different proteins. Therefore, a comprehensive analysis of PTMs in regulatory proteins is essential for elucidating their overall impact on ferroptosis. This review systematically examines the roles of ubiquitination, ubiquitin-like modifications (e.g. UFMylation, SUMOylation), alkylation, and succination in ferroptosis regulation. We highlight how E3 ligases, deubiquitinating enzymes (DUBs), and other PTM-associated enzymes modulate ferroptosis by governing the degradation or stabilization of key targets, thereby influencing redox homeostasis and iron metabolism. Clinically, PTM-targeting agents, including E3 ligase modulators and SUMOylation inhibitors, demonstrate therapeutic potential in preclinical models, though their clinical translation remains in its early stages. This review underscores the complexity of PTM-mediated ferroptosis regulation and highlights the need to explore PTM crosstalk, refine therapeutic strategies, and develop novel PTM modulators for the treatment of malignancies and iron-related disorders.

20 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
HWHaojie Wang
Haojie Wang
YJyaping jiang
yaping jiang
JZJun Ying Zhang
Jun Ying Zhang
XTXiao-Qi Tang
Xiao-Qi Tang
JLJianshu Lou
Jianshu Lou
XHXin-Yun Huang
Xin-Yun Huang
Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in activating naive T cells through presenting antigen information, thereby influencing immunity and anti-cancer responses. Fascin, a 55-kDa actin-bundling protein, is highly expressed in mature DCs and serves as a marker protein for their identification. However, the precise role of fascin in intratumoral DCs remains poorly understood. In this review, we aim to summarize the role of fascin in both normal and intratumoral DCs. In normal DCs, fascin promotes immune effects through facilitating DC maturation and migration. Through targeting intratumoral DCs, fascin inhibitors enhance anti-tumor immune activity. These roles of fascin in different DC populations offer valuable insights for future research in immunotherapy and strategies aimed at improving cancer treatments.